Coronavirus disease (COVID-19), a new form of severe acute respiratory syndrome, has caused a global pandemic. The aim of this study was to analyze homozygous-recessive characteristics (HRC) in the group of COVID-19 patients, considering their gender, forms of the disease (mild and severe symptoms), risk factors: hypertension, diabetes mellitus type 2, hyperlipidemia, smoking habits, and the distribution of ABO blood group. Using the HRC test, we analyzed 20 HRCs in a sample of 321 individuals: 205 patients and 116 controls. The average HRC in patients was significantly higher than controls, as well as in patients with severe symptoms compared to patients with mild symptoms. The patients with higher HRC (cut-off ≤5.5) experienced a significantly increased risk of disease of 2.3 times (OR = 2.315, p < .0005). Our results indicate that the HRC test could be used as a screening in recognizing predisposition for COVID-19.
Al-EitanN. L.AlahmadZ. S. (2021). Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Reviews in Medical Virology, 31, e2194. https://doi.org/10.1002/rmv.2194
2.
AlmadhiM. A.AbdulrahmanA.AlawadhiA.RabaanA. A.AtkinS.AlQahtaniM. (2021). The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes. Scientific Reports, 11(1), 5745. https://doi.org/10.1038/s41598-021-84810-9
3.
Arsić AzanjacA.Drakulić MiletićS.VesićK.TončevG. (2019). ABO blood group and risk of glioma: A case control study from Serbia. Vojnosanitetski Pregled, 76(5), 465–469. https://doi.org/10.2298/VSP161230104A
4.
BadediM.AlnamiA.DarrajH.AlrajhiA.MutawwamD.SomailyM.AlshareefiA.MuhajirA.MajrabiY. (2021). Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia. Medicine, 100(30), e26738. https://doi.org/10.1097/md.0000000000026738
5.
ChakrabortyC.SharmaA. R.BhattacharyaM.SharmaG.LeeS.AgoramoorthyG. (2020). COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. Journal of Medical Virology, 92(11), 2260–2262. https://doi.org/10.1002/jmv.26078
6.
ChenN.ZhouM.DongX.QuJ.GongF.HanY.QiuY.WangJ.LiuY.WeiY.XiaJ.YuT.ZhangX.ZhangL. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
7.
CvjetićaninS.MarinkovićD. (2005). Genetic variability and frequencies of ABO blood types among different samples of patients from Serbia. Korean Journal of Genetics, 27, 35–40.
8.
CvjetićaninS.TerzićM.NikolićD. (2019). Association of rheumatoid arthritis according to the degree of genetic homozygosity and gender: Pilot study. Genetika, 51(3), 1139–1149. http://doi.org/10.2298/GENSR1903139C
9.
DavidSDoradoG.DuarteE. L.David-BosneS.Trigueiro-LouroJ.Rebelo-de-AndradeH. (2022). COVID-19: Impact on public health and hypothesis-driven investigations on genetic susceptibility and severity. Immunogenetics, 74(4), 381–407. https://doi.org/10.1007/s00251-022-01261-w
10.
DelangheJ. R.SpeeckaertM. M.De BuyzereM. L. (2020). COVID-19 infections are also affected by human ACE1 D/I polymorphism. Clinical Chemistry and Laboratory Medicine, 58(7), 1125–1126. https://doi.org/10.1515/cclm-2020-0425
11.
DimitrijevićS.CvjetićaninS.PusicaA.JekićB.FilipovićT.NikolićD. (2018). Anthropogenetic variability in the group of individuals with febrile seizures: Population-genetic study. BioMed Research International, 5, 7845904. https://doi.org/10.1155/2018/7845904
12.
EllinghausD.DegenhardtF.BujandaL.ButiM.AlbillosA.InvernizziP.FernándezJ.PratiD.BaselliG.AsseltaR.GrimsrudM. M.MilaniC.AzizF.KässensJ.MayS.WendorffM.WienbrandtL.Uellendahl-WerthF.ZhengT.KarlsenT. H. (2020). Genomewide association study of severe COVID-19 with respiratory failure. The New England Journal of Medicine, 383, 1522–1534https://doi.org/10.1056/NEJMoa2020283.
13.
FanB. E.ChongV. C. L.ChanS. S. W.LimG. H.LimK. G. E.TanG. B.MucheliS. S.KuperanP.OngK. H. (2020). Hematologic parameters inpatients with COVID-19 infection. The American Journal of Hematology, 95, E131–E153. https://doi.org/10.1002/ajh.25774
14.
Ferreira de AraújoJ. L.MenezesD.Saraiva-DuarteJ. M.de Lima FerreiraL.Santana de AguiarR.Pedra de SouzaR. (2022). Systematic review of host genetic association with COVID-19 prognosis and susceptibility: What have we leaned in 2019?Reviews in Medical Virology, 32(2), e2283. https://doi.org/10.1002/rmv.2283
15.
Figueroa-PizanoM. D.Campa-MadaA. C.Carvajal-MillanE.Martinez-RobinsonK. G.ChuA. R. (2021). The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: A critical review. AIMS Public Health, 8(4), 720–742. https://doi.org/10.3934/publichealth.2021057
16.
Fricke-GalindoI.Falfan-ValenciaR. (2021). Genetics insight for COVID-19 susceptibility and severity: A review. Frontiers in Immunology, 12, 622176. https://doi.org/10.3389/fimmu.2021.622176
17.
Gonzalez-CastroT. B.Hernandez-DiazY.Perez-HernandezN.Tovilla-ZarateC. A.Juarez-RojopI. E.Lopez-NarvaezM. L.Blachman-BraunR.Posadas-SanchezR.Vargas-AlarconG.Garsia-FloresE.Cazarin-SantosB. G.Borgonio-CuadraV. M.Reyes-LopezP. A.Rodriguez-PerezJ. M. (2019). Interleukin 6 (rs1800795) gene polymorphism is associated with cardiovascular diseases: A meta-analysis of 74 studies with 86,229 subjects. EXCLI Journal, 18, 331–355. https://doi.org/10.17179/excli2019-1248
18.
HashemiS. M. A.ThijssenM.HosseiniS. Y.TabarraeiA.PourkarimM. R.SarvariJ. (2021). Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Archives of Virology, 166, 2089–2108. https://doi.org/10.1007/s00705-021-05070-6
19.
HouY.ZhaoJ.MartinW.KallianpurA.ChungM.JehiL.SharifiN.ErzurumS.EngC.ChengF. (2020). New insights into genetic susceptibility of COVID-19: An ACE2 and TMPRSS2 polymorphism analysis. BMC Medicine, 18(1), 216. https://doi.org/10.1186/s12916-020-01673-z
20.
Ibrahim-KostaM.BaillyP.SilvyM.SautN.SuchonP.MorangeP. E.ChiaroniJ.TrégouëtD. A.GoumidiL. (2020). ABO blood group, glycosyltransferase activity and risk of venous thromboembolism. Thrombosis Research, 193, 31–35. https://doi.org/10.1016/j.thromres.2020.05.051
21.
IslamM. R.HoqueM. N.RahmanM. S.AlamA. S. M. R. U.AktherM.PuspoJ. A.AkterS.SultanaM.CrandallK. A.HossainM. A. (2020). Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Scientific Reports, 10, 14004. https://doi.org/10.1038/s41598-020-70812-6
22.
KaranR.CvjetićaninS.Kovačević-KostićN.NikolićD.VelinovićM.MilicevićV.Obrenović-KirčanskiB. (2018). Genetic and environmental dispositions for cardiovascular variability: A pilot study. Journal of Clinical Medicine, 7(9), 232. https://doi.org/10.3390/jcm7090232
23.
KaranR.Obrenović-KirčanskiB.CvjetićaninS.Kovačević-KostićN.VelinovićM.MilicevićV.Vraneš-StoimirovM.NikolicD. (2018). The gender impact on morphogenetic variability in coronary artery disease: A preliminary study. Journal of Clinical Medicine, 7(5), 103. https://doi.org/10.3390/jcm7050103
24.
KatzD. H.TahirU. A.NgoD.BensonM.BickA. G.PampanaA.GaoY.KeyesM. J.CorreaA.SinhaS.ShenD.YangQ.RobbinsJ. M.ChenZ.CruzD. E.PetersonB.NatarajanP.VasanR. S.SmithJ. G.WangT. J.WilsonJ. G.GersztenR. E. (2020). Proteomic profiling in biracial cohorts implicates DC-SIGN as a mediator of genetic risk in COVID-19. MedRxiv.
25.
KumarG.NanchalR.HererraM.SakhujaA.PatelD.MeersmanM.DaltonD.GuddatiA. K. (2021). Does ABO blood groups affect outcomes in hospitalized COVID-19 patients?Journal of Hematology, 10(3), 98–105. https://doi.org/10.14740/jh824
26.
KuoC. L.PillingL. C.AtkinsJ. L.MasoliJ. A. HDelgadoJ.KuchelG. A.MelzerD. (2020) APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. Journals of Gerontology: Series A Biological Sciences and Medical Sciences, 75(11), 2231–2232. https://doi.org/10.1093/gerona/glaa131
27.
LabragueL. J.de Los SantosJ. A. A. (2020). COVID-19 anxiety among front-line nurses: Predictive role of organisational support, personal resilience and social support. Journal of Nursing Management, 28(7), 1653–1661. https://doi.org/10.1111/jonm.13121
28.
LeungT. Y. M.ChanA. Y. L.ChanE. W.ChanV. K. Y.ChuiC. S. L.CowlingB. J.GaoL.GeM. Q.HungI. F. N.IpM. S. M.IpP.LauK. K.LauC. S.LauL. K. W.LeungW. K.LiX.LuoH.ManK. K. C.NgV. W. S.SiuC. W.WanE. Y. F.WingY. K.WongC. S. M.WongK. H. T.WongI. C. K. (2020). Short- and potential long-term adverse health outcomes of COVID-19: A rapid review. Emerging Microbes & Infections, 9(1), 2190–2199. https://doi.org/10.1080/22221751.2020.1825914
29.
LiY.WeiL.HeL.SunJ.LiuN. (2022). Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis. Journal of Infection, 84(6), 825–833. https://doi.org/10.1016/j.jinf.2022.04.029
30.
LoPrestiM.BeckD. B.DuggalP.CummingsD. A. T.SolomonB. D. (2020). The role of host genetic factors in coronavirus susceptibility: Review of animal and systematic review of human literature. American Journal of Human Genetics, 107(3), 381–402. https://doi.org/10.1016/j.ajhg.2020.08.007
31.
ManningJ. T.FinkB. (2020). Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates. Early Human Development, 146, 105074. https://doi.org/10.1016/j.earlhumdev.2020.105074
32.
MarinkovićD.CvjetićaninS. (2007). Population-genetic study of Balkan endemic nephropathy in Serbia. Russian Journal of Genetics, 43, 1134–1138. https://doi.org/10.1134/S1022795407080170
33.
MarinkovićD.CvjetićaninS. (2013). Anthropogenetic homozygosity and adaptive variability: HRC-test in studies of human populations. Monographs DCLXXII, Book 8. Serbian Academy of Sciences and Arts.
34.
MilašinovićS.CvjeticaninS.BrdarR.NikolicD. (2017). Morphogenetic variability and genetic loads among patients with different expression of developmental hip dysplasia. Genetika, 49, 1035–1045. https://doi.org/10.3390/jcm7070162
35.
NguyenA.DavidJ. K.MadenS. K.WoodM. A.WeederB.NelloreA.ThompsonR. (2020). Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. Journal of Virology, 94(13), e00510–e00520. https://doi.org/10.1128/JVI.00510-20.
36.
NikolićD.CvjeticaninS.PetronicI.JekicB.BrdarR.DamnjanovicT.BunjevackiV.MaksimovicN. (2010). Degree of genetic homozygosity and distribution of ABO blood types among patients with spina bifida occulta and spina bifida aperta. Archives of Medical Science, 6, 854–859. https://doi.org/10.5114/aoms.2010.19291
PetronićI.MarinkovicD.NikolicD.CirovicD.GolubovicZ.MilanovicF.CvjeticaninS. (2020). Morphogenetic variability as potential biomarker of neurogenic lesion degree in children with Spina bifida. Healthcare, 8(68), 1–9. https://doi.org/10.3390/healthcare8010068
39.
PorfidiaA.ValerianiE.PolaR.PorrecaE.RutjesA. W. S.Di NisioM. (2020). Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thrombosis Research, 196, 67–74. https://doi.org/10.1016/j.thromres.2020.08.020
40.
Prats-UribeA.XieJ.Prieto-AlhambraD.PetersenI. (2021). Smoking and COVID-19 infection and related mortality: A prospective cohort analysis of UK Biobank data. Clinical Epidemiology, 13, 357–365. https://doi.org/10.2147/CLEP.S300597
41.
Sadeghi-Haddad-ZavarehM.BayaniM.ShokriM.EbrahimpourS.BabazadehA.MehraeenR.MoudiE.RostamiA.BararyM.HosseiniA.BijaniAJavanianM. (2021). C-reactive protein as a prognostic indicator in COVID-19 patients. Interdisciplinary Perspectives on Infectious Disease, 2021, 5557582. https://doi.org/10.1155/2021/5557582
42.
SavićM.CjeticaninS.LazovicM.NikcevicLNikolicD. (2018). Morphogenetic variability and hypertension in ischemic stroke patients—preliminary study. Journal of Clinical Medicine, 7, 162. https://doi.org/10.3390/jcm7070162
43.
SenapatiS.KumarS.SinghA.K.BanerjeeP.BhagavatulaS. (2020). Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human. Journal of Genetics, 99(1), 53. https://doi.org/10.1007/s12041-020-01217-7
44.
ShiebeebS.KhanA. (2022). ABO blood group association and COVID-19. COVID-19 susceptibility and severity: A review. Hematology, Transfusion and Cell Therapy, 44(1), 70–75. https://doi.org/10.1016/j.htct.2021.07.006
45.
Tamayo-VelascoÁ.Peñarrubia-PonceM. J.ÁlvarezF. Jde la FuenteI.Pérez-GonzálezS.Andaluz-OjedaD. (2022). ABO blood system and COVID-19 susceptibility: Anti-A and anti-B antibodies are the key points. Frontiers in Medicine, 9, 882477. https://doi:10.3389/fmed.2022.882477
46.
TongY.WangZ.GengY.LiuJ.ZhangR.LinQ.LiX.HuangD.GaoS.HuD.LiY.ChengJ.LuZ. (2010) The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: Analysis in two Chinese populations. Biochemical and Biophysical Research Communications, 391(1), 481–485. https://doi.org/10.1016/j.bbrc.2009.11.084
47.
TuraleS.MeechamnanC.KunaviktikulW. (2020). Challenging times: ethics, nursing and the COVID-19 pandemic. International Nursing Review, 67(2), 164–167. https://doi.org/10.1111/inr.12598
48.
van der MadeC. I.SimonsA.Schuurs-HoeijmakersJ.van der HeuvelG.MantereT.KersenS.van DeurenR.C.SteehouwerM.van ReijmersdalS. V.JaegerM.HofsteT.AstutiG.Corominas GalbanyJ.van der SchootV.van der HoevenH.Hagmolen of Ten HaveW.KlijnE.van der MeerC.FiddelaersJ.HoischenA. (2020). Presence of genetic variants among young men with severe COVID-19. JAMA, 324(7), 1–11. https://doi.org/10.1001/jama.2020.13719
49.
VelavanT. P.PallerlaS. R.RüterJ.AugustinY.KremsnerP. G.KrishnaS.MeyerC. G. (2021). Host genetic factors determining COVID-19 susceptibility and severity. EbioMedicine, 72, 103629. https://doi.org/10.1016/j.ebiom.2021.103629
50.
WangC.WangZ.WangG.LauJ.ZhangK.LiW. (2021). COVID-19 in early 2021: Current status and looking forward. Signal Transduction and Targeted Therapy, 6, 114. https://www.nature.com/articles/s41392-021-00527-1
51.
WuY.FengZ.LiP.YuQ. (2020). Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clinica Chimica Acta, 509, 220–223. https://doi.org/10.1016/j.cca.2020.06.026.
52.
YamamotoN.AriumiY.NishidaN.YamamotoR.BauerG.GojoboriT.ShimotohnoK.MizokamiM. (2020). SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype. Gene, 758, 144944. https://doi.org/10.1016/j.gene.2020.144944
53.
YamamotoN.YamamotoR.AriumiY.MizokamiM.ShimotohnoK.YoshikuraH. (2021). Does genetic predisposition contribute to the exacerbation of COVID-19 symptoms in individuals with comorbidities and explain the huge mortality disparity between the East and the West?International Journal of Molecular Sciences, 22(9), 5000. https://doi.org/10.3390/ijms22095000
54.
ZguroK.FalleriniC.FavaF.FuriniS.RenieriA. (2022). Host genetic basis of COVID-19: From methodologies to genes. European Journal of Human Genetics, 30(8), 899–907. https://doi.org/10.1038/s41431-022-01121-x
55.
ZhaoJ.YangY.HuangH.LiD.GuD.LuX.ZhangZ.LiuL.LiuT.LiuY.HeY.SunB.WeiM.YangG.WangX.ZhangL.ZhouX.XingM.WangP. G. (2020). Relationship between the ABO blood group and the COVID-19 susceptibility. Clinical Infectious Diseases, 73(2), 328–331. https://doi.org/10.1101/2020.03.11.20031096
56.
ZhaoY.QinL.ZhangP.LiK.LiangL.SunJ.XuB.DaiY.LiX.ZhangC.PengY.FengY.LiA.HuZ.XiangH.OggG.HoL. P.McMichaelA.JinR.. . . ZhangY. (2020). Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight, 5(13), e139834. https://doi.org/10.1172/jci.insight.139834
